GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Change In Receivables

Aprinoia Therapeutics (Aprinoia Therapeutics) Change In Receivables : $0.20 Mil (TTM As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Change In Receivables?

Aprinoia Therapeutics's change in receivables for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Aprinoia Therapeutics's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Aprinoia Therapeutics's change in receivables for the fiscal year that ended in Dec. 2022 was $0.15 Mil. It means Aprinoia Therapeutics's Accounts Receivable declined by $0.15 Mil from Dec. 2021 to Dec. 2022 .

Aprinoia Therapeutics's Accounts Receivable for the quarter that ended in Jun. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aprinoia Therapeutics's Days Sales Outstanding for the six months ended in Jun. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aprinoia Therapeutics's liquidation value for the six months ended in Jun. 2023 was $-88.68 Mil.

Aprinoia Therapeutics Change In Receivables Historical Data

The historical data trend for Aprinoia Therapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Change In Receivables Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22
Change In Receivables
-0.16 0.15

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
Change In Receivables - -0.05 0.20 -

Aprinoia Therapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics  (NAS:APRI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aprinoia Therapeutics's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/9.034*91
=0.00

2. In Ben Graham's calculation of liquidation value, Aprinoia Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Aprinoia Therapeutics's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7.731-96.408+0.75 * 0+0.5 * 0
=-88.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Change In Receivables
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines